Usher syndrome, disease modelling, steps towards personalized medicine and social managemenent of Usher

Splice modulation to treat USH2A-associated retinal degeneration – Erwin Van Wijk, Radboud university medical center, Nijmegen, The Netherlands

iPS cell-derived retinal organoids for disease modelling and development of therapies – Olivier Goureau, Institut de la Vision, Paris, France

Novel insights into the pathomechanisms of human Usher syndrome – Uwe Wolfrum, Mainz University, Germany

Antisense oligonucleotides or gene replacement therapy? Lessons learned from USH1C preclinical studies – Gwenaelle Geleoc, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA

Multimodal representations in primary sensory cortex – Brice Bathellier, Institut de l’Audition, Paris, France

Identification of auditory-neuron subpopulations using ABRs in the presence of ipsilateral broadband masking – Paul Avan, Institut de l’Audition, Paris, France

Human and Social Sciences research on daily life and life paths with Usher syndrome – Sandrine Marlin, Necker Hospital, Paris, France

I Had A Dream – The Power of Usher Families: Identifying the Window of Opportunity to Connect Them to Research and Innovation – Dominique Sturz, Pro Rare Austria, Kritzendorf, Austria

Psychosocial Support Needs of Families with a Child or a Parent with Usher Syndrome – Eline Heppe, Royal Dutch Kentalis, Utrecht, The Netherlands

Burning questions, Wrap-up & Conclusion – Karen Avraham (Tel Aviv University, Israel) / Brice Bathellier (Institut de l’Audition, Paris, France)